Fig. 7From: CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancerSchematic diagram of our hypothesis showing the effect of circLIFR/MutSα/ATM-p73 axis on CDDP chemosensitivity of bladder cancer. CircLIFR could bind to MSH2 protein in nucleus, where it augmented the binding of MutSα with ATM, and contributed to the CDDP sensitivity via pATM-p73 axis in bladder cancerBack to article page